Spearman’s rank test revealed that expression of CHSY1 was positively correlated with CS56 intensity (p = 1.22E − 12, rs = 0.676), indicating that CHSY1 is one of the mediators of CS56 immunoreactivities in glioma tissue. The gene discussed is CHSY1; the disease is central nervous system cancer.